www.3sbio.com 提示:

本信息仅供医学专业人士参考,如果您是医学专业人士,请点击确定后进入。 如果不是,请点击取消。

取消 确定

Products and services

In 3SBio, meeting the needs of patients is the core of all actions.

Our global list of drug combinations

The following is a list of products listed by our company, which is only for medical professionals to refer to.

EPIAO (Recombinant human erythropoietin (rhEPO))

In 1998, EPIAO was marketed with approval of the CFDA, which was the first rhEPO products marketed in China. Since 2002, it has been the leading brand of China’s erythropoin market. It is included in the National Medical Insurance Catalogue as a Category B drug.

Indication Manufacturing base Dosage form & Dosage
Treatment for anemia caused by chronic kidney disease;
Erythrocyte mobilization of peripheral operation;
Treatment for anemia caused by chemotherapy.
Shenyang manufacturing base Penicillin bottle - 2,000 IU/piece, 3,000 IU/piece, 4,000 IU/piece, 10,000 IU/piece, 36,000 IU/piece;
Pre-filled syringe - 2,000 IU/piece, 3,000 IU/piece, 4,000 IU/piece, 10,000 IU/piece.

SEPO (Recombinant human erythropoietin (rhEPO))

CFDA production approval documents were obtained for SEPO in 2001. It was listed in 2002 and is included in the National Medical Insurance Catalogue as a Category B drug. In 2014, SEPO was rated as famous trademark by Guangdong Province Administration for Industry & Commerce.

Indication Manufacturing base Dosage form & Dosage
Treatment for anemia caused by chronic kidney disease;
Treatment for anemia caused by chemotherapy.
Shenzhen manufacturing base Penicillin bottle - 2000IU/1.0ml/piece, 2500IU/1.0ml/piece, 3000IU/1.0ml/piece, 4000IU/1.0ml/piece, 5000IU/1.0ml/piece, 10000IU/1.0ml/piece;
Pre-filled syringe - 2000IU/0.5ml/piece, 2500IU/0.5ml/piece, 3000IU/0.5ml/piece, 4000IU/0.5ml/piece, 5000IU/0.5ml/piece, 10000IU/0.5ml/piece (PFS).

SPARIN (Injectable low-molecular-weight heparin calcium (LMWH-Ca))

SPARIN was approved by the CFDA and listed in 2002. Low-molecular-weight heparin calcium is derived from depolymerization of standard heparin. Compared to standard heparin, low-molecular-weight heparin calcium has the advantages of lower side effects and more predictable anticoagulant response.

Indication Manufacturing base Dosage form & Dosage
The product is used for prophylaxis and treatment of deep vein thrombosis and prevention of clotting during hemodialysis.
Shenzhen manufacturing base /

Jiannipai® (Recombinant humanized anti-CD25 monoclonal antibody injection)

Jiannipai is suitable for prevention of acute rejection after renal transplantation, which can be combined with the routine immunosuppression regime to significantly improve the survival rate of transplanted organs and the quality of life of patients.

Indication Manufacturing base Dosage form & Dosage
The product is suitable for prevention of acute rejection after renal transplantation, which can be combined with the immunosuppression regime containing calcineurin inhibitors and corticosteroid hormone.
Shanghai manufacturing base 25mg/5ml/vial